PIPELINE


  • IT-141 (Novel TOP-I Inhibitor for Colorectal Cancer) leveraging SN-38, a proven anticancer agent

  • IT-139 (Novel GRP78 Inhibitor for BRAF-mutated Metastatic Melanoma) for adjunctive therapy that overcomes drug resistance

ONCOLOGY INDICATION PRECLINICAL PHASE 1 PHASE 2 PHASE 3
IT-139 Metastic Melanoma

IT-139

IT-139

IT-141

IT-141

IT-141 Colorectal Cancer

IT-141

IT-141

IT-141

IT-141

IT-147 Lung Cancer

IT-139

IT-139

IT-141

IT-141


Strategic Overview


Strategic Overview.jpg

Target Indications



FDA Priority Review Programs